Literature DB >> 33328001

[Clinical features of children with immunodeficiency and Mycobacterium tuberculosis infection].

Wen-Ping Wang1, Quan-Bo Liu1.   

Abstract

OBJECTIVE: To study the clinical features of Mycobacterium tuberculosis infection in children with secondary immunodeficiency disease (SID) versus primary immunodeficiency disease (PID).
METHODS: A retrospective analysis was performed on the medical data of children with immunodeficiency and Mycobacterium tuberculosis infection (36 children with SID and 52 with PID) and 108 children with Mycobacterium tuberculosis infection but without immunodeficiency (control group).
RESULTS: The onset age in the PID group was significantly lower than those in the control and SID groups (P < 0.05), and the proportation of males in the PID group was significantly higher than those in the control and SID groups (P < 0.05). Compared with the control group, the SID and PID groups had significantly lower incidence rates of tuberculosis poisoning symptoms (night sweeting, weight loss, fatigue and loss of appetite) and positive rate of PPD test (P < 0.05), as well as a significantly higher incidence rate of the involvement of ≥ 3 pulmonary lobes (P < 0.05). The children with PID tended to have the involvement of multiple organs (P < 0.05). The SID group had a significantly higher incidence rate of miliary shadow on chest CT than the control and PID groups (P < 0.05). The PID group had a significantly lower positive rate of IFN-gamma release assay (IGRA) than the control and SID groups (P < 0.05). Mycobacterium tuberculosis infection manifested as latent tuberculosis infection (36.1%) and active tuberculosis (63.9%) in the SID group. The infection mainly manifested as bacille Calmette-Guérin disease in the PID group (90.4%), among whom 2 children (3.8%) also had tuberculosis.
CONCLUSIONS: Children with immunodeficiency and Mycobacterium tuberculosis infection have atypical clinical symptoms, with a high incidence rate of disseminated infection and low positive rates of PPD and IGRA tests, which may lead to misdiagnosis and missed diagnosis. Children with immunodeficiency should undergo regular tuberculosis screening for early identification and intervention.

Entities:  

Mesh:

Year:  2020        PMID: 33328001      PMCID: PMC7735922     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  19 in total

Review 1.  Tuberculosis in Children.

Authors:  Tania A Thomas
Journal:  Pediatr Clin North Am       Date:  2017-08       Impact factor: 3.278

Review 2.  Latent Mycobacterium tuberculosis infection.

Authors:  Haileyesus Getahun; Alberto Matteelli; Richard E Chaisson; Mario Raviglione
Journal:  N Engl J Med       Date:  2015-05-28       Impact factor: 91.245

Review 3.  Tuberculosis susceptibility and protection in children.

Authors:  Robindra Basu Roy; Elizabeth Whittaker; James A Seddon; Beate Kampmann
Journal:  Lancet Infect Dis       Date:  2018-10-12       Impact factor: 25.071

4.  Prevention of anti-tumor necrosis factor-associated tuberculosis: a 10-year longitudinal cohort study.

Authors:  Laura Muñoz; Susana Casas; Xavier Juanola; Xavier Bordas; Concepcion Martinez; Miguel Santin
Journal:  Clin Infect Dis       Date:  2014-10-13       Impact factor: 9.079

5.  Primary Immunodeficiency Diseases and Bacillus Calmette-Guérin (BCG)-Vaccine-Derived Complications: A Systematic Review.

Authors:  Saba Fekrvand; Reza Yazdani; Peter Olbrich; Andrew Gennery; Sergio D Rosenzweig; Antonio Condino-Neto; Gholamreza Azizi; Hosein Rafiemanesh; Gholamreza Hassanpour; Nima Rezaei; Hassan Abolhassani; Asghar Aghamohammadi
Journal:  J Allergy Clin Immunol Pract       Date:  2020-01-30

6.  Prevalence, incidence, and associated risk factors of tuberculosis in children with HIV living in the UK and Ireland (CHIPS): a cohort study.

Authors:  Anna Turkova; Elizabeth Chappell; Ali Judd; Ruth L Goodall; Steven B Welch; Caroline Foster; Andrew Riordan; Delane Shingadia; Fiona Shackley; Katja Doerholt; Diana M Gibb; Intira J Collins
Journal:  Lancet HIV       Date:  2015-10-29       Impact factor: 12.767

Review 7.  A systemic review of tuberculosis with HIV coinfection in children.

Authors:  Jaishree Naidoo; Nasreen Mahomed; Halvani Moodley
Journal:  Pediatr Radiol       Date:  2017-08-29

8.  Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: A multicentric case-control study in a low-endemic area.

Authors:  Julien Gras; Nathalie De Castro; Claire Montlahuc; Laure Champion; Anne Scemla; Marie Matignon; Marie Lachâtre; Laurent Raskine; Nathalie Grall; Marie Noëlle Peraldi; Jean Michel Molina
Journal:  Transpl Infect Dis       Date:  2018-06-28       Impact factor: 2.228

Review 9.  Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.

Authors:  Stéphanie Boisson-Dupuis; Jacinta Bustamante; Jamila El-Baghdadi; Yildiz Camcioglu; Nima Parvaneh; Safaa El Azbaoui; Aomar Agader; Amal Hassani; Naima El Hafidi; Nidal Alaoui Mrani; Zineb Jouhadi; Fatima Ailal; Jilali Najib; Ismail Reisli; Adil Zamani; Sebnem Yosunkaya; Saniye Gulle-Girit; Alisan Yildiran; Funda Erol Cipe; Selda Hancerli Torun; Ayse Metin; Basak Yildiz Atikan; Nevin Hatipoglu; Cigdem Aydogmus; Sara Sebnem Kilic; Figen Dogu; Neslihan Karaca; Guzide Aksu; Necil Kutukculer; Melike Keser-Emiroglu; Ayper Somer; Gonul Tanir; Caner Aytekin; Parisa Adimi; Seyed Alireza Mahdaviani; Setareh Mamishi; Aziz Bousfiha; Ozden Sanal; Davood Mansouri; Jean-Laurent Casanova; Laurent Abel
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

10.  International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity.

Authors:  Capucine Picard; H Bobby Gaspar; Waleed Al-Herz; Aziz Bousfiha; Jean-Laurent Casanova; Talal Chatila; Yanick J Crow; Charlotte Cunningham-Rundles; Amos Etzioni; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Hans D Ochs; Eric Oksenhendler; Jennifer Puck; Mimi L K Tang; Stuart G Tangye; Troy R Torgerson; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2017-12-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.